Literature DB >> 8887186

The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data.

J C Arpels1.   

Abstract

OBJECTIVE: To propose a theory to help unify the symptoms of premenstrual syndrome (PMS), postpartum blues and depression, the perimenopausal transition and menopause. STUDY
DESIGN: A review of supporting data is used to explain the possible neuroendocrine mechanism upon which the hypothesis is based.
CONCLUSION: The brain in women has been shown to be an estrogen target organ. Common symptoms are shared by women complaining of PMS, postpartum blues, the perimenopausal transition and menopause: depression, sleep disturbance, irritability, anxiety and panic, memory and cognitive dysfunction and a decreased sense of well-being. The antiestrogens progesterone, progestin and tamoxifen may also elicit these same symptoms. It is proposed that whenever brain estrogen levels fall below the minimum brain estrogen requirement, for whatever reason and at whatever age, brain center dysfunction may ensue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887186

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  23 in total

Review 1.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

2.  Overexpression or knockdown of rat tryptophan hyroxylase-2 has opposing effects on anxiety behavior in an estrogen-dependent manner.

Authors:  R Hiroi; R A McDevitt; P A Morcos; M S Clark; J F Neumaier
Journal:  Neuroscience       Date:  2010-12-20       Impact factor: 3.590

3.  Estrogenic regulation of gene and protein expression within the amygdala of female mice.

Authors:  Aaron M Jasnow; Jessica A Mong; Russell D Romeo; Donald W Pfaff
Journal:  Endocrine       Date:  2008-02-05       Impact factor: 3.633

4.  Estrogen decreases 5-HT1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: inverse association between gene expression and anxiety behavior in the open field.

Authors:  R Hiroi; J F Neumaier
Journal:  Neuroscience       Date:  2008-11-01       Impact factor: 3.590

5.  GPR30 is necessary for estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the rat hypothalamus.

Authors:  C E McAllister; R D Creech; P A Kimball; N A Muma; Q Li
Journal:  Psychoneuroendocrinology       Date:  2012-01-20       Impact factor: 4.905

Review 6.  Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-03       Impact factor: 3.568

7.  Effect of endocrine therapy on quality of life and cognitive functions in patients with breast cancer.

Authors:  Saadettin Kilickap; Mutlu Hayran; Banu Cakir; Nesrin Cilingiroglu; Mustafa Erman; Guldal Buyukdamgaci; Yavuz Ozisik
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

Review 8.  Impact of sex steroids and reproductive stage on sleep-dependent memory consolidation in women.

Authors:  Fiona C Baker; Negin Sattari; Massimiliano de Zambotti; Aimee Goldstone; William A Alaynick; Sara C Mednick
Journal:  Neurobiol Learn Mem       Date:  2018-03-21       Impact factor: 2.877

9.  Oral contraceptive use and psychiatric disorders in a nationally representative sample of women.

Authors:  Keely Cheslack-Postava; Katherine M Keyes; Sarah R Lowe; Karestan C Koenen
Journal:  Arch Womens Ment Health       Date:  2014-08-13       Impact factor: 3.633

10.  Longitudinal change of quality of life in the first five years of survival among disease-free Chinese breast cancer survivors.

Authors:  Yuan-Yuan Lei; Suzanne C Ho; Thomas K H Lau; Carol Kwok; Ashley Cheng; Ka Li Cheung; Roselle Lee; Winnie Yeo
Journal:  Qual Life Res       Date:  2021-01-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.